KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) EBIT Margin (2017 - 2025)

Guardant Health (GH) has disclosed EBIT Margin for 9 consecutive years, with 42.95% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 1947.0% to 42.95% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 44.53% through Dec 2025, up 1550.0% year-over-year, with the annual reading at 44.53% for FY2025, 1550.0% up from the prior year.
  • EBIT Margin hit 42.95% in Q4 2025 for Guardant Health, down from 37.33% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 37.33% in Q3 2025 to a low of 137.12% in Q1 2021.
  • Historically, EBIT Margin has averaged 87.58% across 5 years, with a median of 89.03% in 2021.
  • Biggest five-year swings in EBIT Margin: tumbled -8540bps in 2021 and later surged 6497bps in 2024.
  • Year by year, EBIT Margin stood at 90.84% in 2021, then fell by -27bps to 115.15% in 2022, then fell by -11bps to 127.38% in 2023, then skyrocketed by 51bps to 62.42% in 2024, then soared by 31bps to 42.95% in 2025.
  • Business Quant data shows EBIT Margin for GH at 42.95% in Q4 2025, 37.33% in Q3 2025, and 45.85% in Q2 2025.